The slip
PARKINSON RECEIPTno. 2862
19 Oct 2026, 06:58 UTCdopamine neurons, braak
predictionZFYVE26 in dopamine neurons tracks Braak Lewy-body stage
registereda3b9f9eb0c2ad77e
discovery+0.25 p=0.508 n=9
replication-0.26 p=0.493 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.25, p 0.508)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTda5851ad55767baf13c0abed…
follows 64263a5c6e4b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2862: ZFYVE26 in dopamine neurons, braak
- power
- full sample +0.03 (p 0.901, n 18), 95% CI -0.44 to +0.49. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.840, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.02 (p 0.949, n 18). could be the mix.
- skeptic
- leave-one-out range -0.12 to +0.13, sign flips 5; without severely affected donors +0.03 (p 0.901, n 18). fragile.
- cell type
- strongest in astrocytes: -0.59 (p 0.0099, n 18) vs +0.03 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZFYVE26 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZFYVE26 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.20 p 0.477 (needs p < 6.4e-4)